Inspra: new oral aldosterone antagonist coming soonPfizer plans to launch a new aldosterone antagonist, Inspra (eplerenone 25 mg and 50 mg tablets). Weight loss supplements for childhood obesity?Most weight loss supplements should not be recommended for children at this time, according to a recent Canadian review. Best practice guides you keep in your pocket ASTHMA & ALLERGIES: Statins may have role in controlling asthma Delivered by delusional defiance Time runs out as a doctor waits for a mentally ill patient's meds to kick in to see if he'll accept cancer care Vitamin K may boost bone quality in older women Childhood soy intake linked to lower breast CA risk in adults Timing of exposure may be key, study of Asian-Americans finds ARTHROPLASTY: Patients get hip to self-administered rehabilitation Approach equals results from clinics, to which many don't have access anyway Sharpies cut infection risk and environmental waste Canadian study finds preop markers can be reused safely DIGESTIVE DISEASES: IBD flare-ups eased by postpartum breastfeeding Women with inflammatory bowel disease also more likely to complete recommended 24 weeks duration of breastfeeding First Previous 2314 2315 2316 2317 2318 Next Last
